pilocarpine has been researched along with pregabalin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
André, V; Ferrandon, A; Koning, E; Nehlig, A; Rigoulot, MA | 1 |
Cheng, JT; Huang, CC; Huang, CW; Lai, MC; Tsai, JJ; Wu, SN | 1 |
1 review(s) available for pilocarpine and pregabalin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for pilocarpine and pregabalin
Article | Year |
---|---|
Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat.
Topics: Animals; Anticonvulsants; Astrocytes; Brain; Cell Death; Cerebral Cortex; Convulsants; Electroencephalography; Entorhinal Cortex; Epilepsy, Temporal Lobe; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Hippocampus; Immunoenzyme Techniques; Lithium; Neuroprotective Agents; Parahippocampal Gyrus; Pilocarpine; Pregabalin; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2003 |
Pregabalin attenuates excitotoxicity in diabetes.
Topics: Adenosine Triphosphate; Animals; Anticonvulsants; Blood Glucose; Cell Line; Diabetic Neuropathies; Disease Models, Animal; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Glyburide; Hippocampus; KATP Channels; Male; Neurons; Pilocarpine; Potassium Channels, Inwardly Rectifying; Pregabalin; Rats; Seizures; Streptozocin | 2013 |